FMC Corporation (FMC)
| Market Cap | 999.46M -47.3% |
| Revenue (ttm) | 2.81B -22.0% |
| Net Income | -4.26B |
| EPS | -33.38 |
| Shares Out | 155.56M |
| PE Ratio | n/a |
| Forward PE | 5.90 |
| Dividend | $0.32 (4.98%) |
| Ex-Dividend Date | Sep 30, 2026 |
| Volume | 5,265,603 |
| Open | 6.30 |
| Previous Close | 6.09 |
| Day's Range | 6.15 - 6.50 |
| 52-Week Range | 4.37 - 18.29 |
| Beta | 0.46 |
| Analysts | Hold |
| Price Target | 7.91 (+23.16%) |
| Earnings Date | Oct 29, 2026 |
About FMC
FMC Corporation, an agricultural sciences company, develops, markets, and sells crop protection chemicals in Latin America, North America, Europe, the Middle East, Africa, and Asia. The company offers crop protection chemicals, including insecticides, herbicides, and fungicides. It also provides biologicals, crop nutrition, and seed treatment products. It markets its products through its sales organization and alliance partners, independent distributors, and sales representatives. The company was founded in 1883 and is headquartered in Philadel... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 17 analysts, the average rating for FMC stock is "Hold." The 12-month stock price target is $7.91, which is an increase of 23.16% from the latest price.
News
FMC price target lowered to $6.50 from $10 at UBS
UBS lowered the firm’s price target on FMC (FMC) to $6.50 from $10 and keeps a Neutral rating on the shares.
FMC price target raised to $7 from $6 at Citi
Citi raised the firm’s price target on FMC (FMC) to $7 from $6 and keeps a Neutral rating on the shares.
FMC price target lowered to $7 from $9 at RBC Capital
RBC Capital analyst Arun Viswanathan lowered the firm’s price target on FMC (FMC) to $7 from $9 and keeps a Sector Perform rating on the shares. The company’s Q3 results…
FMC price target lowered to $8 from $12 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on FMC (FMC) to $8 from $12 and keeps an Equal Weight rating on the shares.
FMC Corporation Earnings Call Transcript: Q3 2026
Q3 was sharply affected by $672 million of commercial-action charges as channel destocking weakened sales. Updated guidance points to negative FY26 free cash flow, while management expects EBITDA to recover in 2027-28 as pricing, channel flow, new products and manufacturing costs improve.
FMC Corporation Slides: Q3 2026
FMC Corporation has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on October 30, 2026.
FMC Corporation Earnings release: Q3 2026
FMC Corporation released its Q3 2026 earnings on October 30, 2026, summarizing the period's financial results.
FMC Corporation Quarterly report: Q3 2026
FMC Corporation has published its Q3 2026 quarterly earnings report on October 30, 2026.
FMC reports Q3 adjusted EPS ($4.41) vs 89c last year
Reports Q3 revenue $106M vs $436M last year. “We are taking significant action to address elevated inventory values in the channel and improve the movement of FMC (FMC) products to…
FMC Corporation Reports Third-Quarter 2026 Results and Revised Fourth-Quarter Outlook
Company provides additional detail on financial impact of previously announced commercial actions Third Quarter 2026 Highlights Revenue of $106 million, down $436 million versus Q3 2025, including an ...
Lost Money on FMC Corporation Shares? The Law Offices of Frank R.
LOS ANGELES--(BUSINESS WIRE)--FMC Corporation ("FMC" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investig...
Did You Lose Money on FMC Corporation Stock? The Law Offices of Howard G.
BENSALEM, Pa.--(BUSINESS WIRE)--Investors who suffered losses on FMC Corporation ("FMC" or the "Company") stock may have claims to recover those losses. The Law Offices of Howard G. Smith today report...
FMC Investors with $100,000 in Losses Have Opportunity to Join FMC Corporation Fraud Investigation with SBS Law
LOS ANGELES--(BUSINESS WIRE)---- $FMC--FMC Investors with $100,000 in Losses Have Opportunity to Join FMC Corporation Fraud Investigation with SBS Law.
FMC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving FMC Corporation
FMC guided for as much as $140 million in third-quarter adjusted EBITDA, then reset the outlook to a loss of as much as $565 million. The investigation is on behalf of shareholders who lost money in t...
FMC price target lowered to $6 from $12 at Citi
Citi analyst Patrick Cunningham lowered the firm’s price target on FMC (FMC) to $6 from $12 and keeps a Neutral rating on the shares.
FMC Stock Dropped 31%—Why It May Still Be No Bargain
FMC's steep selloff hasn't erased concerns about its debt and inventory problems, while rival Corteva looks more attractive.
FMC price target lowered to $7.50 from $11 at BMO Capital
BMO Capital lowered the firm’s price target on FMC (FMC) to $7.50 from $11 and keeps a Market Perform rating on the shares after the company’s negative Q3 pre-announcement. Years…
FMC downgraded to Hold from Buy at Jefferies
Jefferies downgraded FMC (FMC) to Hold from Buy with a price target of $5, down from $14. To reduce customer inventory and stimulate sales to growers, FMC lowered the price…
FMC downgraded to Neutral from Buy at Seaport Research
Seaport Research analyst Michael Harrison downgraded FMC (FMC) to Neutral from Buy.
FMC price target lowered to $10 from $12 at Mizuho
Mizuho analyst Edlain Rodriguez lowered the firm’s price target on FMC (FMC) to $10 from $12 and keeps an Outperform rating on the shares. FMC is taking a $625M-$650M charge…
Corteva exposure to generic pressure ‘more modest’ than FMC, says Citi
After FMC (FMC) cut revenue and adjusted EBITDA forecasts and noted weaker than expected demand and elevated high-priced channel inventory limiting replenishment demand, Citi notes that the company’s ...
RBC Capital sees negative reaction to FMC’s Q3 preannouncement
RBC Capital tells investors in a research note that FMC (FMC) slashed Q3 EBITDA guidance to $538M from the previous midpoint of $130M, largely due to $650M in commercial actions,…
FMC price target lowered to $4 from $9 at Barclays
Barclays analyst Benjamin Theurer lowered the firm’s price target on FMC (FMC) to $4 from $9 and keeps an Underweight rating on the shares. The company cut its fiscal Q3…
FMC Stock Plummets 38% on Horrendous Guidance
Shares of crop chemical maker FMC plunged Thursday after the company provided deeply disappointing guidance.
FMC Corporation Provides Update to Third-Quarter Expectations and Announces Comprehensive Commercial Actions to Expedite Return to Growth
Third-quarter revenue 1 is now expected to be $65 million to $125 million, with Adjusted EBITDA 2 expected to be negative $565 million to negative $510 million Revised expectations now include commerc...